Market Cap: $58.36B
NI
Natera, Inc.
NTRA
NASDAQ (NASDAQ Global Select)USD
Market Cap: $58.36B
Natera Inc. (Ticker: NTRA) announces a strategic partnership with Eledon Pharmaceuticals to integrate its Prospera test into a significant Phase 3 kidney transplant clinical trial. This collaboration…
Natera (Ticker: NTRA) has made significant strides in transplant diagnostics with the recent presentation of groundbreaking data at the 2026 American Transplant Congress. The new findings link the com…
Natera Inc. (Ticker: NTRA) is making waves in the medical diagnostics industry with groundbreaking data presented at the recent 2026 American Transplant Congress. The company's Prospera test, which pl…
Natera (Ticker: NTRA) is making strides in oncology with a new partnership aimed at revolutionizing personalized cancer care. The company, recognized for its advancements in genetic testing, has recen…
Natera (Ticker: NTRA) recently announces crucial advancements in its Panorama non-invasive prenatal test, addressing significant challenges in fetal fraction sampling. The latest enhancement of the Pa…
Natera, Inc., a pioneer in genetic testing, enhances its presence in transplant diagnostics at the recent International Society for Heart and Lung Transplantation (ISHLT) meeting. The company showcase…
Natera, Inc. showcases groundbreaking clinical findings for its Prospera transplant test at the 2026 ISHLT Annual Meeting, marking a significant milestone in the realm of transplant monitoring. These…
Natera Positions Itself as a Leader in Genetic Testing Innovation Natera, a prominent player in the genetic testing industry, is currently reinforcing its status through persistent innovation, particu…
Natera's Q4 Earnings Reflect Strong Growth and Innovation in Genetic Testing Natera (NASDAQ:NTRA) recently releases its Q4 earnings results, which shed light on the company’s notable growth and advanc…
Natera’s Growth Trajectory in Precision Medicine Highlighted in Q4 Earnings Natera, a prominent player in the genetic testing industry, reveals its Q4 earnings report, showcasing its significant progr…
Natera's Advancements in Genetic Testing Drive Q4 Performance Natera, a prominent player in the precision medicine sector, recently reveals its Q4 earnings, showcasing a significant trajectory in its…
Natera's Strategic Focus on AI Innovations Natera, a leader in genetic testing and diagnostics, operates within a rapidly evolving healthcare landscape that increasingly integrates artificial intellig…
Natera's Strategic Innovations in Genetic Testing Amid AI Advancements Natera, a leader in genetic testing and diagnostics, operates in an industry increasingly influenced by advancements in artificia…
Natera's Pioneering Research in Precision Medicine: Insights from the PALLAS Study Natera Inc. announces preliminary findings from its international randomized Phase 3 PALLAS study, marking a pivotal…
Natera Advances Precision Medicine with PALLAS Study Findings Natera Inc. announces preliminary findings from its international randomized Phase 3 PALLAS study, a significant milestone that underscore…
Natera's PALLAS Study: A Leap Towards Precision Medicine Natera Inc. recently announces preliminary findings from its international randomized Phase 3 PALLAS study, marking a significant milestone in…
Natera Expands Oncology Diagnostics Portfolio with Foresight Acquisition Natera, Inc. has made a significant move in the oncology diagnostics sector by acquiring Foresight Diagnostics for an upfront p…
Natera Expands Oncology Diagnostics Portfolio Through Foresight Acquisition Natera, Inc. announces a strategic acquisition of Foresight Diagnostics, a firm specializing in cancer diagnostics, for an u…
Natera’s Strategic Positioning in the Evolving Landscape of Technology and Healthcare Natera, a leader in genetic testing and diagnostics, finds itself at a pivotal moment as the intersection of techn…
Natera's Strategic Positioning in the Evolving Landscape of Genetic Testing Natera, a leader in prenatal and genetic testing, continues to solidify its position within the rapidly advancing field of p…
Natera's Strategic Focus on Genomic Innovation Natera, a leader in genetic testing and diagnostics, continues to solidify its position in the healthcare sector by enhancing its genomic technologies an…
Natera's Role in Advancing Genetic Testing Solutions Natera, a leader in genetic testing and diagnostics, continues to make significant strides in the healthcare industry. The company specializes in n…
Natera's Role in Advancing Precision Medicine Natera, a leading genetic testing and diagnostics company, continues to play a pivotal role in the evolving landscape of precision medicine. With its focu…
Natera's Role in the Evolving Diagnostics Landscape Natera, a leader in genetic testing and diagnostics, finds itself at the forefront of a rapidly changing healthcare environment. As the demand for n…
Natera Faces Varied Analyst Sentiment Amid Market Dynamics Natera, a leading player in the biotechnology sector, currently experiences a wide spectrum of analyst ratings that reflect mixed sentiments…